The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Open accessAbstract
We show that SARS-CoV-2 spike protein interacts with both cellular heparan sulfate and angiotensin-converting enzyme 2 (ACE2) through its receptor-binding domain (RBD). Docking studies suggest a heparin/heparan sulfate-binding site adjacent to the ACE2-binding site. Both ACE2 and heparin can bind independently to spike protein in vitro, and a ternary complex can be generated using heparin as a scaffold. Electron micrographs of spike protein suggests that heparin enhances the open conformation of the RBD that binds ACE2. On cells, spike protein binding depends on both heparan sulfate and ACE2. Unfractionated heparin, non-anticoagulant heparin, heparin lyases, and lung heparan sulfate potently block spike protein binding and/or infection by pseudotyped virus and authentic SARS-CoV-2 virus. We suggest a model in which viral attachment and infection involves heparan sulfate-dependent enhancement of binding to ACE2. Manipulation of heparan sulfate or inhibition of viral adhesion by exogenous heparin presents new therapeutic opportunities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Self-citationStructure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
Dudley, R. K. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80264-3 · Cited by 5,945
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
RELION: Implementation of a Bayesian approach to cryo-EM structure determination
Scheres, S. H. W. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.09.006 · Cited by 5,446
UCSF ChimeraX: Meeting modern challenges in visualization and analysis
Goddard, T. D., Huang, C. C., Meng, E. C., Pettersen, E. F., Couch, G. S., Morris, J. H., & Ferrin, T. E. (2018) · Protein Science · doi:10.1002/pro.3235 · Cited by 5,267
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020) · Science · doi:10.1126/science.abb2762 · Cited by 5,040
Wiederschain, G. Y. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909090156 · Cited by 4,083
Identification of a major co-receptor for primary isolates of HIV-1
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,641
The ClusPro web server for protein–protein docking
Kozakov, D., Hall, D. R., Xia, B., Porter, K. A., Padhorny, D., Yueh, C., Beglov, D., & Vajda, S. (2017) · Nature Protocols · doi:10.1038/nprot.2016.169 · Cited by 3,310
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P., et al. (1996) · Nature · doi:10.1038/381667a0 · Cited by 3,174
Automated molecular microscopy: The new Leginon system
Suloway, C., Pulokas, J., Fellmann, D., Cheng, A., Guerra, F., Quispe, J., Stagg, S., Potter, C. S., & Carragher, B. (2005) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.03.010 · Cited by 1,764
Site-specific glycan analysis of the SARS-CoV-2 spike
Watanabe, Y., Allen, J. D., Wrapp, D., McLellan, J. S., & Crispin, M. (2020) · Science · doi:10.1126/science.abb9983 · Cited by 1,548
Order Out of Chaos: Assembly of Ligand Binding Sites in Heparan Sulfate
Esko, J. D., & Selleck, S. B. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135458 · Cited by 1,495
Self-citationRemdesivir for the Treatment of Covid-19 — Preliminary Report
(2020) · New England Journal of Medicine · doi:10.1056/nejmc2022236 · Cited by 1,396
Herpes Simplex Virus-1 Entry into Cells Mediated by a Novel Member of the TNF/NGF Receptor Family
Montgomery, R. I., Warner, M. S., Lum, B. J., & Spear, P. G. (1996) · Cell · doi:10.1016/s0092-8674(00)81363-x · Cited by 1,100
A Novel Role for 3-O-Sulfated Heparan Sulfate in Herpes Simplex Virus 1 Entry
Shukla, D., Liu, J., Blaiklock, P., Shworak, N. W., Bai, X., Esko, J. D., Cohen, G. H., Eisenberg, R. J., Rosenberg, R. D., & Spear, P. G. (1999) · Cell · doi:10.1016/s0092-8674(00)80058-6 · Cited by 1,054
Self-citationInitial interaction of herpes simplex virus with cells is binding to heparan sulfate
WuDunn, D., & Spear, P. G. (1989) · Journal of Virology · doi:10.1128/jvi.63.1.52-58.1989 · Cited by 919
Appion: An integrated, database-driven pipeline to facilitate EM image processing
Lander, G. C., Stagg, S. M., Voss, N. R., Cheng, A., Fellmann, D., Pulokas, J., Yoshioka, C., Irving, C., Mulder, A., Lau, P.-W., et al. (2009) · Journal of Structural Biology · doi:10.1016/j.jsb.2009.01.002 · Cited by 835
Demystifying Heparan Sulfate–Protein Interactions
Xu, D., & Esko, J. D. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035314 · Cited by 805
Self-citationHow good is automated protein docking?
Kozakov, D., Beglov, D., Bohnuud, T., Mottarella, S. E., Xia, B., Hall, D. R., & Vajda, S. (2013) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.24403 · Cited by 750
Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19
Kaneko, N., Kuo, H.-H., Boucau, J., Farmer, J. R., Allard-Chamard, H., Mahajan, V. S., Piechocka-Trocha, A., Lefteri, K., Osborn, M., Bals, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.025 · Cited by 734
Self-citationThe war against influenza: discovery and development of sialidase inhibitors
von Itzstein, M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2400 · Cited by 702
New additions to the ClusPro server motivated by CAPRI
Vajda, S., Yueh, C., Beglov, D., Bohnuud, T., Mottarella, S. E., Xia, B., Hall, D. R., & Kozakov, D. (2017) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.25219 · Cited by 604
Voss, N. R., Yoshioka, C. K., Radermacher, M., Potter, C. S., & Carragher, B. (2009) · Journal of Structural Biology · doi:10.1016/j.jsb.2009.01.004 · Cited by 570
Structural basis for human coronavirus attachment to sialic acid receptors
Tortorici, M. A., Walls, A. C., Lang, Y., Wang, C., Li, Z., Koerhuis, D., Boons, G.-J., Bosch, B.-J., Rey, F. A., de Groot, R. J., et al. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0233-y · Cited by 569
Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans.
Shieh, M. T., WuDunn, D., Montgomery, R. I., Esko, J. D., & Spear, P. G. (1992) · The Journal of cell biology · doi:10.1083/jcb.116.5.1273 · Cited by 545
Self-citationKirchdoerfer, R. N., Wang, N., Pallesen, J., Wrapp, D., Turner, H. L., Cottrell, C. A., Corbett, K. S., Graham, B. S., McLellan, J. S., & Ward, A. B. (2018) · Scientific Reports · doi:10.1038/s41598-018-34171-7 · Cited by 466
Self-citationProteoglycans and Sulfated Glycosaminoglycans
Esko, J. D., Kimata, K., & Lindahl, U. (2009) · Europe PMC (PubMed Central) · doi:10.1101/glycobiology.3e.017 · Cited by 450
Self-citationInhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans
Lang, J., Yang, N., Deng, J., Liu, K., Yang, P., Zhang, G., & Jiang, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023710 · Cited by 427
Whitt, M. A. (2010) · Journal of Virological Methods · doi:10.1016/j.jviromet.2010.08.006 · Cited by 426
The versatile heparin in COVID-19
Thachil, J. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14821 · Cited by 404
The sweet spot: defining virus–sialic acid interactions
Stencel-Baerenwald, J. E., Reiss, K., Reiter, D. M., Stehle, T., & Dermody, T. S. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3346 · Cited by 382
Hulswit, R. J. G., Lang, Y., Bakkers, M. J. G., Li, W., Li, Z., Schouten, A., Ophorst, B., van Kuppeveld, F. J. M., Boons, G.-J., Bosch, B.-J., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809667116 · Cited by 380
Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?
Cagno, V., Tseligka, E. D., Jones, S. T., & Tapparel, C. (2019) · Viruses · doi:10.3390/v11070596 · Cited by 376
Mycroft-West, C. J., Su, D., Pagani, I., Rudd, T. R., Elli, S., Gandhi, N. S., Guimond, S. E., Miller, G. J., Meneghetti, M. C. Z., Nader, H. B., et al. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1721319 · Cited by 361
Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19
Li, G., He, X., Zhang, L., Ran, Q., Wang, J., Xiong, A., Wu, D., Chen, F., Sun, J., & Chang, C. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102463 · Cited by 290
Human Coronavirus NL63 Utilizes Heparan Sulfate Proteoglycans for Attachment to Target Cells
Milewska, A., Zarebski, M., Nowak, P., Stozek, K., Potempa, J., & Pyrc, K. (2014) · Journal of Virology · doi:10.1128/jvi.02078-14 · Cited by 289
Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors
Park, Y.-J., Walls, A. C., Wang, Z., Sauer, M. M., Li, W., Tortorici, M. A., Bosch, B.-J., DiMaio, F., & Veesler, D. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0334-7 · Cited by 260
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives
Tandon, R., Sharp, J. S., Zhang, F., Pomin, V. H., Ashpole, N. M., Mitra, D., McCandless, M. G., Jin, W., Liu, H., Sharma, P., et al. (2021) · Journal of Virology · doi:10.1128/jvi.01987-20 · Cited by 260
Roderiquez, G., Oravecz, T., Yanagishita, M., Bou-Habib, D. C., Mostowski, H., & Norcross, M. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2233-2239.1995 · Cited by 242
Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2
Liu, L., Chopra, P., Li, X., Bouwman, K. M., Tompkins, S. M., Wolfert, M. A., de Vries, R. P., & Boons, G.-J. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00010 · Cited by 232
Heparan Sulfate Structure in Mice with Genetically Modified Heparan Sulfate Production
Ledin, J., Staatz, W., Li, J.-P., Götte, M., Selleck, S., Kjellén, L., & Spillmann, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405382200 · Cited by 230
Mycroft-West, C., Su, D., Elli, S., Li, Y., Guimond, S., Miller, G., Turnbull, J., Yates, E., Guerrini, M., Fernig, D., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.29.971093 · Cited by 212
Entry of Human Coronavirus NL63 into the Cell
Milewska, A., Nowak, P., Owczarek, K., Szczepanski, A., Zarebski, M., Hoang, A., Berniak, K., Wojarski, J., Zeglen, S., Baster, Z., et al. (2018) · Journal of Virology · doi:10.1128/jvi.01933-17 · Cited by 195
Lawrence, R., Olson, S. K., Steele, R. E., Wang, L., Warrior, R., Cummings, R. D., & Esko, J. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804288200 · Cited by 193
Self-citationAge-dependent Modulation of Heparan Sulfate Structure and Function
Feyzi, E., Saldeen, T. G. P., Larsson, E., Lindahl, U., & Salmivirta, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13395 · Cited by 144
Initial Step of Virus Entry: Virion Binding to Cell-Surface Glycans
Koehler, M., Delguste, M., Sieben, C., Gillet, L., & Alsteens, D. (2020) · Annual Review of Virology · doi:10.1146/annurev-virology-122019-070025 · Cited by 138
Human milk oligosaccharides inhibit rotavirus infectivityin vitroand in acutely infected piglets
Hester, S. N., Chen, X., Li, M., Monaco, M. H., Comstock, S. S., Kuhlenschmidt, T. B., Kuhlenschmidt, M. S., & Donovan, S. M. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513000391 · Cited by 128
Isolation and characterization of heparan sulfate from various murine tissues
Warda, M., Toida, T., Zhang, F., Sun, P., Munoz, E. M., Xie, J., & Linhardt, R. J. (2006) · Glycoconjugate Journal · doi:10.1007/s10719-006-7668-1 · Cited by 82
Undersulfated and Glycol-Split Heparins Endowed with Antiangiogenic Activity
Casu, B., Guerrini, M., Guglieri, S., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030893g · Cited by 81
Nidovirus Sialate-O-Acetylesterases
Smits, S. L., Gerwig, G. J., van Vliet, A. L. W., Lissenberg, A., Briza, P., Kamerling, J. P., Vlasak, R., & de Groot, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409683200 · Cited by 76
Membrane Protein of Human Coronavirus NL63 Is Responsible for Interaction with the Adhesion Receptor
Naskalska, A., Dąbrowska, A., Szczepański, A., Milewska, A., Jasik, K. P., & Pyrć, K. (2019) · Journal of Virology · doi:10.1128/jvi.00355-19 · Cited by 72
Structural characterization of human liver heparan sulfate
Vongchan, P., Warda, M., Toyoda, H., Toida, T., Marks, R. M., & Linhardt, R. J. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.09.007 · Cited by 65
de Agostini, A. I., Dong, J.-C., Arrighi, C. D. V., Ramus, M. A., Quadri, I. D., Thalmann, S., Ventura, P., Ibéchéole, V., Monge, F., Fischer, A., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805338200 · Cited by 64
Wei, W., Niñonuevo, M. R., Sharma, A., Danan-Leon, L. M., & Leary, J. A. (2011) · Analytical Chemistry · doi:10.1021/ac2001077 · Cited by 56
Kim, S. Y., Jin, W., Sood, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.14.041459 · Cited by 50
Vaccines and Therapies in Development for SARS-CoV-2 Infections
Wu, D. B.-C., Koganti, R., Lambe, U. P., Yadavalli, T., Nandi, S. S., & Shukla, D. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061885 · Cited by 47
Stable heparin-producing cell lines derived from the Furth murine mastocytoma.
Montgomery, R. I., Lidholt, K., Flay, N., et al. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11327 · Cited by 38
Rinninger, A., Richet, C., Pons, A., Kohla, G., Schauer, R., Bauer, H., Zanetta, J., & Vlasak, R. (2006) · Glycoconjugate Journal · doi:10.1007/s10719-006-5439-7 · Cited by 35
Structural analysis of urinary glycosaminoglycans from healthy human subjects
Han, X., Sanderson, P., Nesheiwat, S., Lin, L., Yu, Y., Zhang, F., Amster, I. J., & Linhardt, R. J. (2019) · Glycobiology · doi:10.1093/glycob/cwz088 · Cited by 29
Bioengineering murine mastocytoma cells to produce anticoagulant heparin
Gasimli, L., Glass, C. A., Datta, P. K., Yang, B., Li, G., Gemmill, T. R., Baik, J. Y., Sharfstein, S. T., Esko, J. D., & Linhardt, R. J. (2013) · Glycobiology · doi:10.1093/glycob/cwt108 · Cited by 15
Self-citationAnower-E-Khuda, F., Singh, G., Deng, Y., Gordts, P. L. S. M., & Esko, J. D. (2019) · Glycobiology · doi:10.1093/glycob/cwz037 · Cited by 14
Self-citation
Cited by
A guide to the composition and functions of the extracellular matrix
Karamanos, N. K., Theocharis, A. D., Piperigkou, Z., Manou, D., Passi, A., Skandalis, S. S., Vynios, D. H., Orian‐Rousseau, V., Ricard‐Blum, S., Schmelzer, C. E. H., et al. (2021) · The FEBS Journal · doi:10.1111/febs.15776 · Cited by 1,090
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
The ATTACC, A.-4. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2105911 · Cited by 1,046
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
McCallum, M., De Marco, A., Lempp, F. A., Tortorici, M. A., Pinto, D., Walls, A. C., Beltramello, M., Chen, A., Liu, Z., Zatta, F., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.028 · Cited by 901
“SARS-CoV-2 S also engages cell-surface heparan-sulfates (Clausen et al., 2020), neuropilin-1 (Cantuti-Castelvetri et al.”
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
ATTACC Investigators, ACTIV-4a Investigators, REMAP-CAP Investigators, Lawler, P. R., Goligher, E. C., Berger, J. S., Neal, M. D., McVerry, B. J., Nicolau, J. C., Gong, M. N., et al. (n.d.) · Bern Open Repository and Information System (University of Bern) · doi:10.17863/cam.76384 · Cited by 581
Wang, S., Qiu, Z., Hou, Y., Deng, X., Xu, W., Zheng, T., Wu, P., Xie, S., Bian, W., Zhang, C., et al. (2021) · Cell Research · doi:10.1038/s41422-020-00460-y · Cited by 499
Metadata
- Authors
- Clausen, T. M., Sandoval, D. R., Spliid, C. B., Pihl, J., Perrett, H. R., Painter, C. D., Narayanan, A., Majowicz, S. A., Kwong, E. M., McVicar, R. N., Thacker, B. E., Glass, C. A., Yang, Z., Torres, J. L., Golden, G. J., Bartels, P. L., Porell, R. N., Garretson, A. F., Laubach, L., Feldman, J., Yin, X., Pu, Y., Hauser, B. M., Caradonna, T. M., Kellman, B. P., Martino, C., Gordts, P. L. S. M., Chanda, S. K., Schmidt, A. G., Godula, K., Leibel, S. L., Jose, J., Corbett, K. D., Ward, A. B., Carlin, A. F., & Esko, J. D.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 183
- Issue
- 4
- Pages
- 1043-1057.e15
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W3085153423
- Cited by
- 1,136
- References
- 66
- FWCI
- 24.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.